secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2024-02-01T23:59:59+00:00
Accession:  0001493152-24-004562
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Semper Paratus shareholders approve merger with Tevogen Bio; redemptions ~$15.9M
--------------------------------------------------------------------------------

- Shareholders approved all proposals, including business combination, domestication, and charter changes.
- Approximately 1.43M public shares redeemed for ~$15.9M (~$11.07 per share) from trust.
- Combined company expected to trade on Nasdaq as 'TVGN' after closing.
- Elected board: Dr. Curtis Patton, Jeffrey Feike, Surendra Ajjarapu, Victor Sordillo, Dr. Keow Lin Goh, Dr. Ryan Saadi, Susan Podlogar.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224004562/0001493152-24-004562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000149315224004562/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-004562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer